2m 2m 2m 2m 2m 2m 2m
GENPREX (GNPX)
NASDAQ
$2.65+$0.09 (+3.52%)
Price as of Oct 02, 2026 6:00 PM EDT- $2.1MMarket Cap
- -98.84%1-Year Change
- BiotechnologyIndustry
GENPREX (GNPX)
$2.65+$0.09 (+3.52%)
GNPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.56 | ||
Change | -$0.36 (-12.33%) | ||
Open | $2.98 | ||
High | $2.98 | ||
Low | $2.53 | ||
Previous Close | $2.92 | ||
Volume | 148,264 | ||
30-Day Average Volume | 209,241 | ||
1-Week Change | -27.27% | ||
1-Month Change | -27.89% | ||
1-Year Change | -98.84% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 819,709 | ||
Total Assets | $17.1M | ||
Market Cap | $2.1M | ||
Enterprise Value | -$13.1M | ||
Period: QTR TTM FY | |||
Revenue | $541.00 | ||
Net Income | -$4.5M | ||
Free Cash Flow | -$3.1M | ||
EBIT | -$4.5M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $15.4M | ||
EPS | -$14.08 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | -29,484 | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 22 | ||
Last Split Date | 07/16/2026 | ||
Earnings & Revenue